Colcrys

URL Pharma Launches Co-Pay Assistance Program for Colcrys (R) today announced the launch of the Colcrys® (colchicine, USP) Co-Pay Assistance Program, an initiative designed to save

WN.com - Articles related to ‘SMS therapy’ for chronic diseases 2010

URL Pharma went through such steps, and last summer received approval to exclusively market its colchicine product, which it dubbed Colcrys, for gout attacks for three years.

URL Pharma Under Fire for Letters to Doctors Who Criticized Drug 2010

Three years later, multiple versions of the drug remain available; yet only one, called Colcrys, has been approved by the Food and Drug Administration (FDA) as safe and effective.

John Horton: Drugs Should Meet 2010 Standards for Drug Safety John Horton 2010

Only one version of the anti-gout medicine, called Colcrys, is approved by the FDA, although numerous unapproved versions remain available in the US.

John Horton: Unapproved Drugs Mixed With HIV Medications Can be a Risky Prescription 2010

When a prescription drug called Colcrys came on the market last fall to treat gout, a number of physicians voiced their displeasure on an online message board for rheumatologists.

URL Pharma Under Fire for Letters to Doctors Who Criticized Drug 2010

When the US Food and Drug Administration in July 2009 approved a new formulation of colchicine, called Colcrys, it gave the manufacturer three years of market exclusivity under rules that encourage compliance with the FDA's drug-approval process.

Boston.com Top Stories 2011

URL Pharma priced Colcrys much higher than the pennies a tablet that patients had been paying for the older colchicine saying it was costly to conduct the clinical testing and the price was in line with other approved gout treatments.

URL Pharma Under Fire for Letters to Doctors Who Criticized Drug 2010

Ms. Morrison said she plans to get help from URL Pharma to pay for Colcrys because the company has just expanded its assistance program.

An Old Gout Drug Gets New Life and a New Price, Riling Patients Jonathan D. Rockoff 2010

After obtaining FDA approval of Colcrys, URL Pharma went to federal court to sue manufacturers of colchicine, including Excellium Pharmaceutical Inc.,

An Old Gout Drug Gets New Life and a New Price, Riling Patients Jonathan D. Rockoff 2010

In his postings, he had criticized URL Pharma for conducting limited research and for its pricing of Colcrys.

URL Pharma Under Fire for Letters to Doctors Who Criticized Drug 2010